South Korean FDA Probes Roche for Aiding Tamiflu Stockpiling
By Shirley S. Wang
Should companies be allowed to buy large quantities of medicine like Tamiflu to have on hand in case their employees develop the H1N1 flu virus? Not according to the law in South Korea, where it’s illegal for non-medical professionals to purchase big lots of drugs. Punishment is up to five years in prison.
The law is at the center of a probe of Tamiflu maker Roche, which is being investigated by the Korean … Continue Reading
Evidence-based medicine sounds straightforward enough, but (like everything else in health care) it’s become pretty contentious. The argument against evidence-based care says, more or less, that no two patients are alike, so doctors must be flexible in their use of evidence and can’t be bound by rigid protocols based on large studies.
IMS Health is nearing a deal to sell itself for nearly $4 billion, the WSJ reports. That raises a simple question: What does IMS Health do, anyway?
The pharmaceutical industry is undergoing big cuts and the U.S. unemployment rate hit its highest mark since April 1983, but the health-care services sector continues to grow, according to the Bureau of Labor Statistics. 
Sorry about all those exclamation marks in the headline. But there’s lots of action in DC today, what with the House set to vote on the big health-care bill this Saturday.